DSpace@İnönü

Investigation of serum minimal inhibitory concentrations of some

Basit öğe kaydını göster

dc.contributor.author Durmaz, R
dc.contributor.author Koroglu, M
dc.contributor.author Kucukbay, H
dc.contributor.author Temel, I
dc.contributor.author Ozer, MK
dc.contributor.author Refiq, M
dc.contributor.author Cetinkaya, E
dc.contributor.author Cetinkaya, B
dc.contributor.author Yologlu, S
dc.date.accessioned 2022-03-04T13:46:37Z
dc.date.available 2022-03-04T13:46:37Z
dc.date.issued 1998
dc.identifier.uri http://hdl.handle.net/11616/54386
dc.description.abstract In previous studies many benzimidazole, imidazole and benzothiazole derivatives had been synthesized and their antimicrobial activities were tasted in vitro conditions. Four of these compounds showed minimal inhibitory concentrations (MIC) of 5-25 mu g/ml against standard strains and clinical isolates. In order to determine whether these four compounds can be used for therapeutic purpose, their serum MIC values and side effects on hepatic and renal functions were determined. Different concentrations of the compounds were tested on Wistar rats. Compound 1 was administered orally, intramuscularly and intravenously; compounds 2, 3 and 4 were given orally and intramuscularly. Blood samples were taken 4 and 24 h after administration of the compounds. Serum MIC Values were investigated by bioassay and serum levels of biochemical parameters by autoanalyzer. None of the tested compounds showed antimicrobial activity at their serum concentrations. Although creatinine activity was found at normal levels in all experiments, compounds 1 and 2 caused a significant increase in blood urea nitrogen (BUN) level. The values of aspartate aminotransferase and/or alanine aminotransferase and/or alkaline phosphatase which are characteristic for liver function were generally found at high levels. According to these results, it can be concluded that the tested compounds caused damage in liver and biliary tracts without antimicrobial activity by their serum concentrations.
dc.source ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH
dc.title Investigation of serum minimal inhibitory concentrations of some
dc.title benzimidazole, imidazole and benzothiazole derivatives and their effects
dc.title on liver and renal functions


Bu öğenin dosyaları:

Dosyalar Boyut Biçim Göster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster